Anzeige
Mehr »
Dienstag, 15.07.2025 - Börsentäglich über 12.000 News
Diese Aktie zeigt die wissenschaftliche Schlagkraft hinter ihrer KI-gesteuerten Krebsforschung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0JKUU | ISIN: NO0010205966 | Ticker-Symbol: N1A
Frankfurt
14.07.25 | 21:47
1,910 Euro
+3,24 % +0,060
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
NAVAMEDIC ASA Chart 1 Jahr
5-Tage-Chart
NAVAMEDIC ASA 5-Tage-Chart

Aktuelle News zur NAVAMEDIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoNavamedic ASA - Minutes of Extraordinary General Meeting156OSLO, Norway, July 14, 2025 /PRNewswire/ -- The announced Extraordinary General Meeting of Navamedic ASA was held today at 13.00 CET. All items on the agenda were approved in accordance with...
► Artikel lesen
MoXFRA CAPITAL ADJUSTMENT INFORMATION - 14.07.2025100Das Instrument 8L8C US5303073051 LIBERTY BROADBAND C EQUITY wird cum Kapitalmassnahme gehandelt am 14.07.2025 und ex Kapitalmassnahme am 15.07.2025 The instrument 8L8C US5303073051 LIBERTY BROADBAND...
► Artikel lesen
FrNavamedic ASA: Mandatory notice of trade1
DoNavamedic ASA: Updated key information relating to the rights issue-
29.06.Navamedic ASA - Additional underwriting commitments in the Rights Issue1
27.06.Navamedic ASA: First approval of the medical device OraFID as primary package for a pharmaceutical product279OSLO, Norway, June 27, 2025 /PRNewswire/ -- Navamedic announces that the Swedish Medical Products Agency, acting as the Reference Member State, together with the Concerned Member States in...
► Artikel lesen
24.06.Navamedic signs agreement to acquire dne pharma2
24.06.Navamedic ASA - Investor presentation regarding the acquisition of the business of dne pharma AS203OSLO, Norway, June 24, 2025 /PRNewswire/ -- Reference is made to the announcement made by Navamedic ASA (the "Company" or "Navamedic", and OSE ticker "NAVA") yesterday, on June 23, regarding...
► Artikel lesen
NAVAMEDIC Aktie jetzt für 0€ handeln
23.06.Navamedic ASA: Mandatory notice of trade-
23.06.Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in connection with a contemplated rights issue-
23.06.Navamedic ASA: Key information relating to the Rights Issue2
23.06.Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue293NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR...
► Artikel lesen
04.06.Navamedic ASA: Minutes of Annual General Meeting1
14.05.Navamedic ASA: Notice of Annual General Meeting1
05.05.Navamedic ASA launches Eroxon® in Denmark2
30.04.Navamedic ASA: Annual Report 2024302OSLO, Norway, April 30, 2025 /PRNewswire/ -- Navamedic ASA has today published its Annual Report for 2024. Find enclosed the report in PDF as well as an ESEF file version. The report is also...
► Artikel lesen
30.04.Navamedic ASA: Navamedic Q1 2025: Strong start of the year and well-positioned for future growth241OSLO, Norway, April 30, 2025 /PRNewswire/ -- In the first quarter of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health...
► Artikel lesen
30.04.Navamedic Q1 2025 presentation: Revenue up 9.2%, EBITDA jumps 52% despite wider net loss4
29.04.Navamedic ASA: Imdur distribution agreement extended to 2032334OSLO, Norway, April 29, 2025 /PRNewswire/ -- Navamedic ASA (OSE: NAVA) today announced it has signed a renewed distribution agreement with TopRidge Pharma Limited (TopRidge) for Imdur®, valid...
► Artikel lesen
28.04.Navamedic ASA: Conclusion received from the Norwegian Financial Supervisory Authority-
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1